Aortic Repair Devices Market Outlook: 6.8% CAGR to 2033
Aortic Repair Devices by Product Type (Stent Grafts, Catheters), by Procedure Type (Abdominal Aortic Aneurysm Repair, Open Repair, Endovascular Aneurysm Repair, Thoracic Aortic Aneurysm Repair, Thoracic Endovascular Aneurysm Repair and Others), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
Aortic Repair Devices Market Outlook: 6.8% CAGR to 2033
Discover the Latest Market Insight Reports
Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.
About Market Data Pulse
Market Data Pulse is a market intelligence and research platform that helps organizations interpret changing markets, identify growth opportunities, and make informed strategic decisions. We provide syndicated market research reports, customized research solutions, competitive intelligence, and data-driven advisory support for businesses operating in rapidly evolving global industries. Market Data Pulse delivers timely insights into market size, market share, demand patterns, pricing developments, technology adoption, consumer behavior, regulatory shifts, and the competitive landscape. Our research is designed to support decision-makers at every stage of planning—from market entry and product development to investment evaluation, expansion strategy, and risk assessment.
Our analysts combine structured desk research, industry databases, company disclosures, trade information, expert inputs, and qualitative and quantitative analytical methods. This multi-source approach helps us develop practical market assessments that go beyond headline statistics and explain the forces shaping an industry. Market Data Pulse serves professionals across sectors including technology, healthcare, energy, chemicals and materials, food and beverage, consumer goods, retail, manufacturing, automotive, logistics, financial services, and emerging business segments. We focus on translating complex data into clear, decision-ready intelligence that can help companies monitor market momentum and respond with confidence. Whether clients need an off-the-shelf report, a tailored market forecast, competitor benchmarking, customer analysis, or a focused opportunity assessment, Market Data Pulse aims to provide relevant insights with clarity, consistency, and commercial value.
The Aortic Repair Devices Market is valued at USD 5.58 billion in 2025 and is projected to reach USD 9.45 billion by 2033, expanding at a 6.8% CAGR. Within the broader Cardiovascular Devices Market, aortic repair is one of the few categories where procedure volume growth outpaces general hospital capital spending, because endovascular repair moves treatment out of the operating theatre and into catheter-based intervention.
Aortic Repair Devices Market Size (In Billion)
10.0B
8.0B
6.0B
4.0B
2.0B
0
5.580 B
2025
5.959 B
2026
6.365 B
2027
6.797 B
2028
7.260 B
2029
7.753 B
2030
8.281 B
2031
Three forces define the current cycle:
Procedure migration. Endovascular aneurysm repair and thoracic endovascular aortic repair now account for most elective abdominal and thoracic interventions in the United States, Germany, and Japan.
Technology iteration. Low-profile delivery systems, fenestrated and branched stent grafts, and polymer-sealed endografts widen the treatable anatomy pool.
Reimbursement stability. Separate coding for endovascular aortic procedures supports hospital adoption even where capital budgets are constrained.
North America holds 38.0% of global revenue on the strength of aortic screening rates and mature vascular surgery networks. Asia-Pacific is the fastest-moving region at a projected 9.1% CAGR, driven by hospital expansion in China and India. Europe, at roughly 26.0% share, is the most regulation-intensive market following EU MDR implementation, which lengthened device certification timelines and consolidated the supplier base.
What the Numbers Imply
The 6.8% baseline CAGR assumes no change in reimbursement policy and continued migration toward endovascular first-line repair.
A one-point acceleration in endovascular penetration adds roughly USD 40–55 million in annual category revenue.
Revenue growth is weighted toward stent graft and delivery system innovation rather than unit volume alone.
Strategic implication: vendors that shorten catheter profile, extend the seal zone, and reduce re-intervention rates capture a disproportionate share of premium-priced procedures performed in Hospitals Market settings and hybrid operating rooms.
Aortic Repair Devices Company Market Share
Loading chart...
Segment Deep-Dive: Stent Grafts Dominance in Aortic Repair Devices Market
Segment Analysis Matrix
Segment
CAGR 2025–2033 (%)
Market Share 2025 (%)
Key Demand Driver
Stent Grafts (Product Type)
7.2%
68%
Shift to endovascular first-line repair and approval of fenestrated and branched devices
Catheters (Product Type)
5.6%
32%
Delivery system replacement cycles and low-profile access for complex anatomy
Abdominal Aortic Aneurysm Repair
6.4%
55%
Prevalence in men over 65 and national screening programmes
Thoracic Aortic Aneurysm Repair
7.9%
24%
Dissection incidence and expansion of thoracic endovascular repair into arch anatomy
Stent Grafts: The Revenue Engine
The Aortic Stent Graft Market generates roughly 68% of category revenue. Growth concentrates in two device classes:
Fenestrated and branched endografts for juxtarenal and thoracoabdominal aneurysms, where open surgery carries materially higher mortality.
Polymer-sealed and active-seal devices that reduce type II endoleak rates and lower the probability of secondary intervention.
Margins in this sub-segment are structurally high. Gross margins typically run 70–78% because each device is anatomy-specific, produced in low volumes, and sold under physician preference. That advantage is partly offset by regulatory documentation costs, particularly in Europe, where each design change triggers notified body review.
Catheters and Delivery Systems
The Vascular Catheters Market for aortic repair is smaller but strategically decisive. Delivery sheath profile, trackability, and tip deflection determine whether a patient is treatable endovascularly. Vendors now compete on 14–16 French low-profile systems that extend eligibility to patients with narrow iliac access vessels. Pricing here is more commoditized, with gross margins closer to 45–55%, and contract manufacturers in Malaysia and Mexico pressure average selling prices.
Procedure Mix Dynamics
The Endovascular Aneurysm Repair Market is the volume anchor, expanding as screening programmes identify asymptomatic aneurysms earlier in the disease course.
Open Repair retains share in ruptured presentations and connective tissue disease, but volume growth is flat to slightly negative in high-income markets.
The Thoracic Endovascular Aneurysm Repair Market is the fastest-growing procedure class, supported by dissection registries and improved conformability in the aortic arch.
Increasing number of endovascular procedures replacing open repair
High
Short term
Driver
Device innovation: low-profile, fenestrated, and branched endografts
High
Medium term
Driver
National aortic screening programmes in the US and UK
Medium
Medium term
Driver
Hybrid operating room investment and imaging integration
Medium
Long term
Restraint
Limited device availability in developing regions
High
Short term
Restraint
Complicated post-procedure requirements and re-intervention
High
Long term
Restraint
EU MDR certification burden and notified body capacity
Medium
Medium term
Restraint
Physician training bottleneck for complex fenestrated cases
Medium
Short term
Catalysts
Endovascular migration is the largest quantitative driver. Each percentage point shift from open repair to endovascular repair raises category revenue by roughly USD 40–55 million, because an endograft plus delivery system typically prices at 2.5–4x a surgical graft. Demand from the Minimally Invasive Surgical Devices Market reinforces the same shift: access ports, guidewires, and imaging catheters are frequently bundled into a single procedure. Device innovation compounds the effect, and fenestrated and branched grafts expand the treatable population by an estimated 15–20% of thoracic and juxtarenal anatomies previously restricted to surgery.
Bottlenecks
Supply inequality. Several aortic platforms remain unregistered in Latin America, Africa, and parts of Southeast Asia, where import registration takes 18–36 months.
Re-intervention economics. Five-year secondary intervention rates of 8–14% raise total cost of care and invite payer prior-authorization controls.
Regulatory drag. EU MDR re-certification removed a share of legacy endografts from the European catalogue between 2021 and 2024, narrowing physician choice and lengthening lead times.
Net effect: driver impact outweighs restraint impact by roughly 2:1 through 2033, supporting the 6.8% baseline CAGR.
Broad endograft portfolio spanning abdominal and thoracic platforms
High-volume vascular surgery centers
Leader
W. L. Gore & Associates
ePTFE material science and long-term durability data
Academic and hybrid OR programs
Leader
Terumo Aortic
Custom fenestrated and branched grafts
Complex thoracoabdominal referral centers
Leader
Cook Medical, Inc.
Zenith platform with multi-year registry evidence
National health systems and tenders
Leader
Endologix, Inc.
Abdominal systems with lower-profile delivery
Community hospitals and ASCs
Challenger
JOTEC GmbH
European thoracic stent grafts and hybrid accessories
EU and MEA hospital networks
Challenger
Lombard Medical Technologies
Cost-competitive abdominal endografts
Price-sensitive emerging markets
Niche
MicroPort Scientific Corporation
Domestic China endograft manufacturing
Chinese provincial hospital networks
Challenger
Cardiatis
Multilayer flow modulator technology
Specialized complex aneurysm cases
Niche
VASCUTEK Ltd.
Surgical grafts for open and hybrid repair
Open repair and hybrid procedures
Niche
Vendor Profiles
Medtronic PLC: The largest aortic franchise, with abdominal and thoracic endograft families covering the widest indication set. Hybrid OR partnerships and physician training programs sustain share in North America and Western Europe.
W. L. Gore & Associates: Vertically integrated in ePTFE, which gives it material cost control across its endograft lines. Its clinical evidence base supports premium positioning in durability-sensitive referral centers.
Terumo Aortic: Custom-manufactured fenestrated and branched devices place it in the highest-acuity referral centers, where case margins are widest.
Cook Medical, Inc.: Multi-year registry data on its Zenith platform supports tender wins with national procurement bodies and central purchasing agencies.
Endologix, Inc.: Focused on abdominal systems with lower-profile delivery, competing on procedural efficiency in community hospitals.
JOTEC GmbH: A European specialist with strong thoracic coverage, benefiting from regional distribution and hybrid procedure accessories.
MicroPort Scientific Corporation: Localized manufacturing in China supports provincial tender pricing and shortens lead times versus imported endografts.
Lombard Medical Technologies: Niche position built on cost-competitive abdominal devices for markets with low reimbursement ceilings.
Cardiatis: Flow modulator technology addresses complex aneurysm morphologies that standard endografts cannot treat.
VASCUTEK Ltd.: Supplies surgical grafts used in open and hybrid repair, retaining relevance where endovascular access is unfavorable.
Strategic Milestones & Recent Developments in Aortic Repair Devices Market
Expanded fenestrated indications in Europe and Japan
2023
W. L. Gore & Associates
Clinical data release
Long-term durability evidence strengthened thoracic position
2023
MicroPort Scientific Corporation
Capacity expansion
Domestic endograft output scaled for provincial tenders
2022
JOTEC GmbH
Distribution partnership
Broadened Middle East and North Africa hospital access
2022
Endologix, Inc.
Portfolio restructuring
Refocused investment on abdominal platform economics
Development Detail
2024 – Delivery system downsizing. Lower-profile sheaths reduced access-vessel complications, historically the leading cause of procedure abandonment.
2023–2024 – Fenestrated expansion. Custom and off-the-shelf fenestrated grafts moved from compassionate use into routine reimbursement in several European markets.
2022–2023 – Regional manufacturing. Localization in China and Mexico shortened lead times and reduced exposure to cross-border logistics disruption.
2022 – Portfolio discipline. Several vendors divested non-core peripheral lines to concentrate R&D on aortic platforms, where gross margins exceed 70%.
Consolidation is likely to continue. Smaller aortic specialists with single-platform portfolios face rising EU MDR and FDA documentation costs that scale poorly below USD 150 million in annual category revenue.
Endovascular procedure volume and screening reimbursement
High (FDA PMA and 510(k))
Europe
5.4%
1.45
Fenestrated device adoption in Germany and the UK
Very high (EU MDR)
Asia-Pacific
9.1%
1.34
Hospital expansion in China and India
Medium to high
South America
6.6%
0.34
Private hospital investment in Brazil
Medium
Middle East & Africa
7.3%
0.33
GCC specialty center build-out
Medium
Regional Insights
North America (38.0% of global revenue). Mature but not saturated: endovascular penetration among eligible abdominal aneurysm patients remains below 70%, and thoracic repair sits earlier on its adoption curve.
Europe. The most regulation-intensive region. EU MDR re-certification narrowed the supplier field, and national tenders in Italy and Spain cap average selling price growth. Germany and the United Kingdom remain the technology-adoption leaders.
Asia-Pacific (fastest-growing). China's domestic endograft approvals and India's private hospital expansion drive volume. Japan is the most mature APAC market, with high thoracic endovascular penetration and a 2.5% annual procedure growth baseline.
LAMEA. Brazil and the GCC are the priority corridors. Import registration timelines and reimbursement gaps in North Africa and Rest of South America limit near-term revenue.
Average selling prices vary sharply by device class:
Abdominal endografts: USD 8,000–14,000 per unit.
Thoracic stent grafts: USD 12,000–22,000 per unit.
Fenestrated or branched custom devices: above USD 25,000 per unit.
The Medical Grade Polymers Market and the Titanium Alloys Market sit upstream of this pricing stack. ePTFE, polyester graft fabric, and nitinol are the three largest material inputs, and vendors with vertical integration into ePTFE hold a 6–9 percentage point gross margin advantage over assemblers that buy finished materials.
Pricing Power
Preference-item status protects ASPs inside individual hospitals, but group purchasing organization contracts compress them at the system level.
Custom fenestrated devices are effectively price-inelastic because no substitute exists for a given anatomy.
Commodity catheters face the sharpest price erosion, with annual declines of 2–4% in tendered European markets.
Margin Outlook
Gross margin for the category is expected to settle in a 62–70% band through 2033, down modestly from current levels as regulatory documentation costs and sterilization expenses grow faster than ASPs.
The United States and Western Europe are net exporters of high-value endografts, with Ireland, Germany, and the Netherlands functioning as primary European distribution hubs.
China is shifting from net importer to regional exporter as provincial manufacturers gain approvals in ASEAN and Central Asian markets.
Mexico and Malaysia supply catheter shafts and delivery system subassemblies, making finished-device landed cost sensitive to tariff changes of 5–15%.
Tariff and Non-Tariff Exposure
Duty changes on medical device inputs feed directly into delivery system COGS, which represent roughly 15–20% of endograft cost. Non-tariff barriers matter more than tariffs overall: registration lead times of 18–36 months in emerging markets delay revenue recognition, and local-content or localization rules increasingly require in-country assembly for public tender eligibility.
Strategic Response
Dual-source critical subassemblies across at least two customs jurisdictions.
Pre-position inventory in Europe and the GCC ahead of tender cycles.
Localize final assembly where public procurement rules require it, accepting a modest margin trade-off in exchange for volume access.
Aortic Repair Devices Segmentation
1. Product Type
1.1. Stent Grafts
1.2. Catheters
2. Procedure Type
2.1. Abdominal Aortic Aneurysm Repair
2.2. Open Repair
2.3. Endovascular Aneurysm Repair
2.4. Thoracic Aortic Aneurysm Repair
2.5. Thoracic Endovascular Aneurysm Repair and Others
Aortic Repair Devices Segmentation By Geography
1. North America
1.1. United States
1.2. Canada
1.3. Mexico
2. South America
2.1. Brazil
2.2. Argentina
2.3. Rest of South America
3. Europe
3.1. United Kingdom
3.2. Germany
3.3. France
3.4. Italy
3.5. Spain
3.6. Russia
3.7. Benelux
3.8. Nordics
3.9. Rest of Europe
4. Middle East & Africa
4.1. Turkey
4.2. Israel
4.3. GCC
4.4. North Africa
4.5. South Africa
4.6. Rest of Middle East & Africa
5. Asia Pacific
5.1. China
5.2. India
5.3. Japan
5.4. South Korea
5.5. ASEAN
5.6. Oceania
5.7. Rest of Asia Pacific
Aortic Repair Devices Regional Market Share
Loading chart...
Aortic Repair Devices Regional Market Share
Higher Coverage
Lower Coverage
No Coverage
Aortic Repair Devices REPORT HIGHLIGHTS
Aspects
Details
Study Period
2020-2034
Base Year
2025
Estimated Year
2026
Forecast Period
2026-2034
Historical Period
2020-2025
Growth Rate
CAGR of 6.8% from 2020-2034
Segmentation
By Product Type
Stent Grafts
Catheters
By Procedure Type
Abdominal Aortic Aneurysm Repair
Open Repair
Endovascular Aneurysm Repair
Thoracic Aortic Aneurysm Repair
Thoracic Endovascular Aneurysm Repair and Others
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
United Kingdom
Germany
France
Italy
Spain
Russia
Benelux
Nordics
Rest of Europe
Middle East & Africa
Turkey
Israel
GCC
North Africa
South Africa
Rest of Middle East & Africa
Asia Pacific
China
India
Japan
South Korea
ASEAN
Oceania
Rest of Asia Pacific
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Objective
1.4. Definitions and Assumptions
2. Executive Summary
2.1. Market Snapshot
3. Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Trends
3.4. Market Opportunity
4. Market Factor Analysis
4.1. Porters Five Forces
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL analysis
4.3. BCG Analysis
4.3.1. Stars (High Growth, High Market Share)
4.3.2. Cash Cows (Low Growth, High Market Share)
4.3.3. Question Mark (High Growth, Low Market Share)
4.3.4. Dogs (Low Growth, Low Market Share)
4.4. Ansoff Matrix Analysis
4.5. Supply Chain Analysis
4.6. Regulatory Landscape
4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
4.8. MPU Analyst Note
5. Market Analysis, Insights and Forecast, 2020-2034
5.1. Market Analysis, Insights and Forecast - by Product Type
5.1.1. Stent Grafts
5.1.2. Catheters
5.2. Market Analysis, Insights and Forecast - by Procedure Type
5.2.1. Abdominal Aortic Aneurysm Repair
5.2.2. Open Repair
5.2.3. Endovascular Aneurysm Repair
5.2.4. Thoracic Aortic Aneurysm Repair
5.2.5. Thoracic Endovascular Aneurysm Repair and Others
5.3. Market Analysis, Insights and Forecast - by Region
5.3.1. North America
5.3.2. South America
5.3.3. Europe
5.3.4. Middle East & Africa
5.3.5. Asia Pacific
6. North America Market Analysis, Insights and Forecast, 2020-2034
6.1. Market Analysis, Insights and Forecast - by Product Type
6.1.1. Stent Grafts
6.1.2. Catheters
6.2. Market Analysis, Insights and Forecast - by Procedure Type
6.2.1. Abdominal Aortic Aneurysm Repair
6.2.2. Open Repair
6.2.3. Endovascular Aneurysm Repair
6.2.4. Thoracic Aortic Aneurysm Repair
6.2.5. Thoracic Endovascular Aneurysm Repair and Others
7. South America Market Analysis, Insights and Forecast, 2020-2034
7.1. Market Analysis, Insights and Forecast - by Product Type
7.1.1. Stent Grafts
7.1.2. Catheters
7.2. Market Analysis, Insights and Forecast - by Procedure Type
7.2.1. Abdominal Aortic Aneurysm Repair
7.2.2. Open Repair
7.2.3. Endovascular Aneurysm Repair
7.2.4. Thoracic Aortic Aneurysm Repair
7.2.5. Thoracic Endovascular Aneurysm Repair and Others
8. Europe Market Analysis, Insights and Forecast, 2020-2034
8.1. Market Analysis, Insights and Forecast - by Product Type
8.1.1. Stent Grafts
8.1.2. Catheters
8.2. Market Analysis, Insights and Forecast - by Procedure Type
8.2.1. Abdominal Aortic Aneurysm Repair
8.2.2. Open Repair
8.2.3. Endovascular Aneurysm Repair
8.2.4. Thoracic Aortic Aneurysm Repair
8.2.5. Thoracic Endovascular Aneurysm Repair and Others
9. Middle East & Africa Market Analysis, Insights and Forecast, 2020-2034
9.1. Market Analysis, Insights and Forecast - by Product Type
9.1.1. Stent Grafts
9.1.2. Catheters
9.2. Market Analysis, Insights and Forecast - by Procedure Type
9.2.1. Abdominal Aortic Aneurysm Repair
9.2.2. Open Repair
9.2.3. Endovascular Aneurysm Repair
9.2.4. Thoracic Aortic Aneurysm Repair
9.2.5. Thoracic Endovascular Aneurysm Repair and Others
10. Asia Pacific Market Analysis, Insights and Forecast, 2020-2034
10.1. Market Analysis, Insights and Forecast - by Product Type
10.1.1. Stent Grafts
10.1.2. Catheters
10.2. Market Analysis, Insights and Forecast - by Procedure Type
10.2.1. Abdominal Aortic Aneurysm Repair
10.2.2. Open Repair
10.2.3. Endovascular Aneurysm Repair
10.2.4. Thoracic Aortic Aneurysm Repair
10.2.5. Thoracic Endovascular Aneurysm Repair and Others
11. Competitive Analysis
11.1. Company Profiles
11.1.1. Terumo Aortic
11.1.1.1. Company Overview
11.1.1.2. Products
11.1.1.3. Company Financials
11.1.1.4. SWOT Analysis
11.1.2. Cardiatis
11.1.2.1. Company Overview
11.1.2.2. Products
11.1.2.3. Company Financials
11.1.2.4. SWOT Analysis
11.1.3. Cook Medical Inc.
11.1.3.1. Company Overview
11.1.3.2. Products
11.1.3.3. Company Financials
11.1.3.4. SWOT Analysis
11.1.4. Endologix Inc.
11.1.4.1. Company Overview
11.1.4.2. Products
11.1.4.3. Company Financials
11.1.4.4. SWOT Analysis
11.1.5. JOTEC GmbH
11.1.5.1. Company Overview
11.1.5.2. Products
11.1.5.3. Company Financials
11.1.5.4. SWOT Analysis
11.1.6. Lombard Medical Technologies
11.1.6.1. Company Overview
11.1.6.2. Products
11.1.6.3. Company Financials
11.1.6.4. SWOT Analysis
11.1.7. Medtronic PLC
11.1.7.1. Company Overview
11.1.7.2. Products
11.1.7.3. Company Financials
11.1.7.4. SWOT Analysis
11.1.8. W. L. Gore and Associates
11.1.8.1. Company Overview
11.1.8.2. Products
11.1.8.3. Company Financials
11.1.8.4. SWOT Analysis
11.1.9. VASCUTEK Ltd.
11.1.9.1. Company Overview
11.1.9.2. Products
11.1.9.3. Company Financials
11.1.9.4. SWOT Analysis
11.1.10. MicroPort Scientific Corporation
11.1.10.1. Company Overview
11.1.10.2. Products
11.1.10.3. Company Financials
11.1.10.4. SWOT Analysis
11.1.11. W. L. Gore & Associates
11.1.11.1. Company Overview
11.1.11.2. Products
11.1.11.3. Company Financials
11.1.11.4. SWOT Analysis
11.2. Market Entropy
11.2.1. Company's Key Areas Served
11.2.2. Recent Developments
11.3. Company Market Share Analysis, 2026
11.3.1. Top 5 Companies Market Share Analysis
11.3.2. Top 3 Companies Market Share Analysis
11.4. List of Potential Customers
12. Research Methodology
List of Figures
Figure 1: Aortic Repair Devices Revenue Breakdown (billion, %) by Region 2026 & 2034
Figure 2: North America Aortic Repair Devices Revenue (billion), by Product Type 2026 & 2034
Figure 3: North America Aortic Repair Devices Revenue Share (%), by Product Type 2026 & 2034
Figure 4: North America Aortic Repair Devices Revenue (billion), by Procedure Type 2026 & 2034
Figure 5: North America Aortic Repair Devices Revenue Share (%), by Procedure Type 2026 & 2034
Figure 6: North America Aortic Repair Devices Revenue (billion), by Country 2026 & 2034
Figure 7: North America Aortic Repair Devices Revenue Share (%), by Country 2026 & 2034
Figure 8: South America Aortic Repair Devices Revenue (billion), by Product Type 2026 & 2034
Figure 9: South America Aortic Repair Devices Revenue Share (%), by Product Type 2026 & 2034
Figure 10: South America Aortic Repair Devices Revenue (billion), by Procedure Type 2026 & 2034
Figure 11: South America Aortic Repair Devices Revenue Share (%), by Procedure Type 2026 & 2034
Figure 12: South America Aortic Repair Devices Revenue (billion), by Country 2026 & 2034
Figure 13: South America Aortic Repair Devices Revenue Share (%), by Country 2026 & 2034
Figure 14: Europe Aortic Repair Devices Revenue (billion), by Product Type 2026 & 2034
Figure 15: Europe Aortic Repair Devices Revenue Share (%), by Product Type 2026 & 2034
Figure 16: Europe Aortic Repair Devices Revenue (billion), by Procedure Type 2026 & 2034
Figure 17: Europe Aortic Repair Devices Revenue Share (%), by Procedure Type 2026 & 2034
Figure 18: Europe Aortic Repair Devices Revenue (billion), by Country 2026 & 2034
Figure 19: Europe Aortic Repair Devices Revenue Share (%), by Country 2026 & 2034
Figure 20: Middle East & Africa Aortic Repair Devices Revenue (billion), by Product Type 2026 & 2034
Figure 21: Middle East & Africa Aortic Repair Devices Revenue Share (%), by Product Type 2026 & 2034
Figure 22: Middle East & Africa Aortic Repair Devices Revenue (billion), by Procedure Type 2026 & 2034
Figure 23: Middle East & Africa Aortic Repair Devices Revenue Share (%), by Procedure Type 2026 & 2034
Figure 24: Middle East & Africa Aortic Repair Devices Revenue (billion), by Country 2026 & 2034
Figure 25: Middle East & Africa Aortic Repair Devices Revenue Share (%), by Country 2026 & 2034
Figure 26: Asia Pacific Aortic Repair Devices Revenue (billion), by Product Type 2026 & 2034
Figure 27: Asia Pacific Aortic Repair Devices Revenue Share (%), by Product Type 2026 & 2034
Figure 28: Asia Pacific Aortic Repair Devices Revenue (billion), by Procedure Type 2026 & 2034
Figure 29: Asia Pacific Aortic Repair Devices Revenue Share (%), by Procedure Type 2026 & 2034
Figure 30: Asia Pacific Aortic Repair Devices Revenue (billion), by Country 2026 & 2034
Figure 31: Asia Pacific Aortic Repair Devices Revenue Share (%), by Country 2026 & 2034
List of Tables
Table 1: Aortic Repair Devices Revenue billion Forecast, by Product Type 2020 & 2034
Table 2: Aortic Repair Devices Revenue billion Forecast, by Procedure Type 2020 & 2034
Table 3: Aortic Repair Devices Revenue billion Forecast, by Region 2020 & 2034
Table 4: North America Aortic Repair Devices Revenue billion Forecast, by Product Type 2020 & 2034
Table 5: North America Aortic Repair Devices Revenue billion Forecast, by Procedure Type 2020 & 2034
Table 6: North America Aortic Repair Devices Revenue billion Forecast, by Country 2020 & 2034
Table 7: United States Aortic Repair Devices Revenue (billion) Forecast, by Application 2020 & 2034
Table 46: Rest of Asia Pacific Aortic Repair Devices Revenue (billion) Forecast, by Application 2020 & 2034
Research Methodology & Data Sources
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
Primary Research
Research split: Primary research accounts for 70–80% of total study input, with secondary research contributing the remaining 20–30%. Primary work is executed through structured interviews, procurement-level surveys, and follow-up validation calls.
Company types interviewed in the aortic repair value chain: endograft and stent graft OEMs producing thoracic and abdominal devices; vascular catheter and delivery sheath manufacturers; contract manufacturers of nitinol frames and ePTFE graft material; hospital and ambulatory surgery center procurement groups that purchase aortic devices; and regulatory affairs consultancies handling FDA and EU MDR submissions.
Stakeholder job titles interviewed: Vascular Surgery Department Procurement Directors; Chiefs of Vascular and Endovascular Surgery; Interventional Radiology Department Managers; Regulatory Affairs and Quality Assurance Leads; and Supply Chain and Materials Sourcing Managers.
Industry bodies and regulators referenced: Society for Vascular Surgery (vascular.org), European Society for Vascular Surgery (esvs.org), U.S. FDA Center for Devices and Radiological Health (fda.gov), and ISO 13485 quality management standards (iso.org).
Report currency: Every report is updated to the date of purchase, so all figures reflect the most recent quarterly filings, regulatory clearances, and tender awards available at delivery.
Key Stakeholders Interviewed
Key Stakeholders Interviewed
Stakeholder Role
Interview Share (%)
Vascular Surgery Department Procurement Directors
28%
Chiefs of Vascular and Endovascular Surgery
24%
Interventional Radiology Department Managers
22%
Regulatory Affairs and Quality Assurance Leads
16%
Supply Chain and Materials Sourcing Managers
10%
Industry Ecosystem Breakdown
Industry Ecosystem Breakdown
Company Type
Representation (%)
Stent Graft and Endograft OEMs
34%
Vascular Catheter and Delivery System Manufacturers
24%
Hospital and ASC Procurement Groups
18%
Contract Manufacturers and Nitinol Component Suppliers
Regulatory and clinical evidence is sourced from .gov and .org domains, including FDA 510(k) and PMA databases, EUDAMED device registrations, and peer-reviewed registry publications from national vascular surgery societies.
Company-level benchmarking uses annual reports, investor presentations, and tender award notices, cross-checked against trade association statistics on aortic procedure volumes.
No market research aggregator websites are used as primary sources; all third-party data points are traced back to an originating regulator, registry, or corporate filing.
Demand Modeling & Market Estimation
Top-down and bottom-up methods run simultaneously. The top-down model begins with global cardiovascular device spending and isolates the aortic repair share using procedure-mix ratios. The bottom-up model builds revenue from device units sold per procedure class, multiplied by average selling price, then scaled to region.
Multi-level data triangulation reconciles the two models against vendor-level revenue disclosures, import and export records, and hospital purchasing data. Divergence above 7% between models triggers a re-interview round.
Quantitative metrics used in the bottom-up calculation:
Annual endovascular and open aortic repair procedure volume per 100,000 population aged 65 and older.
Number of hybrid operating rooms and catheterization laboratories equipped for aortic intervention per million population.
Average selling price per endograft by device class (abdominal, thoracic, fenestrated, branched).
Five-year secondary intervention and re-intervention rate per device platform, used to adjust effective lifetime revenue per implant.
Screening-eligible population under national abdominal aortic aneurysm screening programmes.
Segment and regional splits are reconciled to the product type (stent grafts, catheters) and procedure type (abdominal repair, open repair, endovascular aneurysm repair, thoracic repair, thoracic endovascular repair and others) taxonomy used throughout the report.
Data Accuracy & Quality Check
Guaranteed estimated data accuracy level of 85–90% across all market sizing and forecast outputs.
Every quantitative claim passes a three-stage check: source verification against the originating document, internal consistency testing against adjacent segments, and sanity testing against historical growth rates.
Forecast assumptions are stress-tested under high, baseline, and low scenarios, with the baseline reflecting current reimbursement policy and regulatory timelines.
Interview transcripts and survey responses are retained for audit, and any data point that cannot be traced to a named source is excluded from the final model.
Reports are refreshed to the date of purchase, so regulatory decisions or supply disruptions occurring after the base year are incorporated before delivery.
Frequently Asked Questions
1. What product and procedure segments make up the Aortic Repair Devices Market?
The market splits by product into stent grafts (roughly 68% of revenue) and catheters and delivery systems (about 32%), and by procedure into abdominal aortic aneurysm repair, open repair, endovascular aneurysm repair, thoracic aortic aneurysm repair, and thoracic endovascular aneurysm repair. Endovascular procedures are taking share from open surgery because they shorten hospital stay and reduce perioperative mortality. Abdominal indications remain the largest procedure block at around 55% of category revenue.
2. How large is the Aortic Repair Devices Market and what CAGR is projected through 2033?
The market was valued at USD 5.58 billion in 2025 and is forecast to reach approximately USD 9.45 billion by 2033, a 6.8% CAGR over the 2025–2033 period. Stent grafts carry the higher growth rate at about 7.2%, while catheters and delivery systems advance nearer 5.6%. Thoracic endovascular repair is the fastest-growing procedure class at roughly 7.9% annually.
3. What are the biggest challenges restraining growth in the Aortic Repair Devices Market?
Device availability remains uneven: several endograft platforms are unregistered across parts of Latin America, Africa, and Southeast Asia, where import registration can take 18 to 36 months. Post-procedure complexity adds a second constraint, with secondary intervention rates of 8% to 14% at five years raising total cost of care and triggering payer prior-authorization reviews. EU MDR re-certification has also removed legacy devices from the European catalogue, narrowing physician choice.
4. Which regulations shape device approval and compliance in the Aortic Repair Devices Market?
In the United States, the FDA Center for Devices and Radiological Health governs market access through PMA and 510(k) pathways, with post-market surveillance obligations for endografts. In Europe, EU MDR 2017/745 requires notified body conformity assessment and has extended certification timelines for design changes. ISO 13485 quality management certification is a baseline requirement across most national procurement tenders, and design changes to fenestrated grafts typically trigger fresh regulatory review.
5. Which region is the fastest-growing in the Aortic Repair Devices Market and where are the emerging opportunities?
Asia-Pacific is the fastest-growing region at a projected 9.1% CAGR, supported by hospital expansion in China and India and growing domestic endograft manufacturing. China's provincial tender system and India's private hospital investment are the two largest volume drivers. Brazil and the GCC are the leading emerging opportunities outside Asia, though reimbursement listing gaps in North Africa and Rest of South America limit near-term revenue.
6. Why do sustainability and ESG factors matter in the Aortic Repair Devices Market?
Sterilization and packaging are the main environmental pressure points, with ethylene oxide emissions drawing regulatory attention in the United States and Europe. Several manufacturers are shifting toward lower-emission sterilization methods and recyclable sterile barrier packaging to reduce waste from single-use delivery systems. Material sourcing also matters: nitinol and cobalt-chromium supply chains face conflict-mineral disclosure rules, and ePTFE production carries fluoropolymer scrutiny under EU chemical regulations.
